A listed company, based on the field of independent medical laboratory/forensic identification/diagnostic product sales/diagnostic technology research and development, an independent third-party medical diagnostic service organization specializing in providing diagnostic service outsourcing business
Zhejiang Dian Diagnostic Technology Co., Ltd., founded in 2001, is an independent third-party medical diagnostic service organization with the core business of providing diagnostic service outsourcing. With its unique integrated business model of "service and product", it has become a pioneer and advocate in the industry, and was the first to be listed in July 2011 (stock code: 300244), achieving a "zero breakthrough" in the listing of China's independent medical laboratories.
Dian Diagnostics is committed to providing customers with "integrated solutions for medical diagnosis services", and actively promotes the multi-service field expansion of the third-party independent medical diagnosis platform and the integrated development strategy of the upstream and downstream industry chain, covering medical diagnosis services, diagnostic products and services marketing, judicial appraisal, health examination business, cold chain logistics, diagnostic technology R&D and production, CRO, biobank and other fields. At present, it has more than 30 chain laboratories across the country, and has successively passed the ISO15189 and CAP international quality certification and accreditation system, providing services for more than 12,000 medical institutions across the country.
Dian focuses on the innovation of diagnostic technology platforms, and has been approved as the first batch of high-throughput gene sequencing technology pilot units for tumor diagnosis and treatment projects in China, the first batch of national demonstration centers for clinical application of genetic testing technology, and the national third-party high-performance medical diagnosis and treatment equipment application demonstration center. It has reached strategic cooperation with many internationally renowned institutions such as Johns Hopkins University in the United States, NMS in the United States, Maryland Department of Justice in the United States, and SCL Health Management Group in South Korea.
With the deepening of the new medical improvement process, the intensification of social aging and the rise of personalized diagnosis and treatment, Dian will take advantage of the vigorous development of the big health service industry, give full play to the advantages of unique business model, innovative technology research and development, and perfect management system, with the mission of "let the Chinese people share health equally", create a big health industry ecosystem, and achieve a win-win situation for medical institutions, the government and the people.
